Determining the Structure and Mode of Action of Microbisporicin, a Potent Lantibiotic Active Against Multiresistant Pathogens

Allgaier, 1986, Epidermin: sequencing of a heterodectic tetracyclic 21-peptide amide antibiotic, Eur. J. Biochem., 160, 9, 10.1111/j.1432-1033.1986.tb09933.x Appelbaum, 2006, The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus, Clin. Microbiol. Infect., 12, 16, 10.1111/j.1469-0691.2006.01344.x Bax, 1985, MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy, J. Magn. Reson., 65, 355 Billot-Klein, 1997, Presence of UDP-N-acetylmuramyl-hexapeptides and -heptapeptides in enterococci and staphylococci after treatment with ramoplanin, tunicamycin, or vancomycin, J. Bacteriol., 179, 4684, 10.1128/jb.179.15.4684-4688.1997 Bonelli, 2006, Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies, Antimicrob. Agents Chemother., 50, 1449, 10.1128/AAC.50.4.1449-1457.2006 Breukink, 1999, Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic, Science, 286, 2361, 10.1126/science.286.5448.2361 Brotz, 1997, The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation, Eur. J. Biochem., 246, 193, 10.1111/j.1432-1033.1997.t01-1-00193.x Brotz, 1998, The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II, Antimicrob. Agents Chemother., 42, 154, 10.1128/AAC.42.1.154 Brotz, 1998, Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics, Mol. Microbiol., 30, 317, 10.1046/j.1365-2958.1998.01065.x Castiglione, 2007, A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp, Biochemistry, 46, 5884, 10.1021/bi700131x Chan, 1996, Structure-activity relationships in the peptide antibiotic nisin: antibacterial activity of fragments of nisin, FEBS Lett., 390, 129, 10.1016/0014-5793(96)00638-2 Chatterjee, 2005, Biosynthesis and mode of action of lantibiotics, Chem. Rev., 105, 633, 10.1021/cr030105v Chatterjee, 1992, Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity, J. Antibiot. (Tokyo), 45, 839, 10.7164/antibiotics.45.839 Cierpicki, 2001, Amide proton temperature coefficients as hydrogen bond indicators in proteins, J. Biomol. NMR, 21, 249, 10.1023/A:1012911329730 Corti, 1985, Solid-phase enzyme-receptor assay (SPERA): a competitive-binding assay for glycopeptide antibiotics of the vancomycin class, Clin. Chem., 31, 1606, 10.1093/clinchem/31.10.1606 Cotter, 2005, Bacterial lantibiotics: strategies to improve therapeutic potential, Curr. Protein Pept. Sci., 6, 61, 10.2174/1389203053027584 Finney, 1952, The Spearman -Kärber method, 524 French, 2006, Bactericidal agents in the treatment of MRSA infections—the potential role of daptomycin, J. Antimicrob. Chemother., 58, 1107, 10.1093/jac/dkl393 Griesinger, 1988, Clean TOCSY for 1H spin system identification in macromolecules, J. Am. Chem. Soc., 110, 7870, 10.1021/ja00231a044 Hasper, 2006, An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II, Science, 313, 1636, 10.1126/science.1129818 Hsu, 2003, NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity, J. Biol. Chem., 278, 13110, 10.1074/jbc.M211144200 Hsu, 2004, The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics, Nat. Struct. Mol. Biol., 11, 963, 10.1038/nsmb830 Johnson, 2002, Glycopeptide-resistant Staphylococcus aureus, J. Antimicrob. Chemother., 50, 621, 10.1093/jac/dkf244 Jung, 1991, Lantibiotics—a survey, 1 Jung, 2006, Enzyme-catalyzed sulfide ring formation in lantibiotics, Angew. Chem. Int. Ed. Engl., 45, 5919, 10.1002/anie.200601850 Kohlrausch, 1991, One-step purification procedure for UDP-N-acetylmuramyl-peptide murein precursors from Bacillus cereus, FEMS Microbiol. Lett., 62, 253, 10.1111/j.1574-6968.1991.tb04451.x Komiyama, 1993, A new antibiotic, cypemycin. Taxonomy, fermentation, isolation and biological characteristics, J. Antibiot. (Tokyo), 46, 1666, 10.7164/antibiotics.46.1666 Lazzarini, 2001, Rare genera of actinomycetes as potential producers of new antibiotics, Antonie Van Leeuwenhoek, 79, 399 Lazzarini, A., Gastaldo, L., Candiani, P., Ciciliato, I., Losi, D., Marinelli, F., Selva, E., and Parenti, F. (2005). Antibiotics 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof. International Publication Number WO 2005/014628 A, International Publication Date 17 February 2005. Machaidze, 2003, Specific binding of cinnamycin (Ro 09–0198) to phosphatidylethanolamine. Comparison between micellar and membrane environments, Biochemistry, 42, 12570, 10.1021/bi035225b Meiring, 2002, Nanoscale LC-MS(n): technical design and applications to peptide and protein analysis, J. Sep. Sci., 25, 557, 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F 1990 Pag, 2002, Multiple activities in lantibiotics—models for the design of novel antibiotics?, Curr. Pharm. Des., 8, 815, 10.2174/1381612023395439 Parenti, 1990, Ramoplanin: a review of its discovery and its chemistry, Drugs Exp. Clin. Res., 16, 451 Parenti, 1976, Gardimycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies, J. Antibiot. (Tokyo), 29, 501, 10.7164/antibiotics.29.501 Pawlowska, 1993, Enantiomeric separation of fluorescent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, tagged amino acids, J. Chromatogr., 641, 257, 10.1016/0021-9673(93)80142-U Ruzin, 2004, Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria, Antimicrob. Agents Chemother., 48, 728, 10.1128/AAC.48.3.728-738.2004 Simpson, 1976, Complete amino acid analysis of proteins from a single hydrolysate, J. Biol. Chem., 251, 1936, 10.1016/S0021-9258(17)33637-2 Somma, 1977, Gardimycin, a new antibiotic inhibiting peptidoglycan synthesis, Antimicrob. Agents Chemother., 11, 396, 10.1128/AAC.11.3.396 Stein, 2002, Two different lantibiotic-like peptides originate from the ericin gene cluster of Bacillus subtilis A1/3, J. Bacteriol., 184, 1703, 10.1128/JB.184.6.1703-1711.2002 Walsh, 2003, Antibiotics that block cell wall biosynthesis, 23 Wiedemann, 2001, Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity, J. Biol. Chem., 276, 1772, 10.1074/jbc.M006770200 Wishart, 1998, Protein chemical shift analysis: a practical guide, Biochem. Cell Biol., 76, 153, 10.1139/o98-038 Wüthrich, 1986